Previously associated with a lower incidence of gout, sodium-glucose cotransporter-2 (SGLT2) inhibitors for the first time also appear to reduce gout flare recurrence and excess mortality.
Patients with gout who achieve and maintain target serum urate levels through urate-lowering therapy demonstrate a reduced risk for fractures, according to data published in Arthritis & Rheumatology.
Patients with hand synovial abnormalities in osteoarthritis demonstrate an abundance of two specific species of gut microbiota, according to findings presented at the 2022 OARSI World Congress.